©2024 Stanford Medicine
Overcoming Barriers and Obstacles to Adopting Diabetes Devices (ONBOARD) Trial
Recruiting
I'm InterestedTrial ID: NCT04672655
Purpose
This study is a comprehensive, multicomponent behavioral intervention package (ONBOARD; OvercomiNg Barriers \& Obstacles to Adopting Diabetes Devices). ONBOARD will provide adults with T1D the skills to maximize benefit and minimize daily interference from barriers associated with Continuous Glucose Monitoring (CGM) and increase readiness for closed loop.
Official Title
Overcoming Barriers and Obstacles to Adopting Diabetes Devices (ONBOARD) Trial
Stanford Investigator(s)
Molly Tanenbaum
Clinical Assistant Professor, Medicine - Endocrinology, Gerontology, & Metabolism Clinical Assistant Professor (By courtesy), Pediatrics - Endocrinology and Diabetes
Marina Basina
Clinical Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Eligibility
Inclusion Criteria:
1. Subject is age 18-50 years at time of enrollment
2. Subject must not have been using CGM regularly for past 6 months
3. Subject has a clinical diagnosis of type 1 diabetes
4. Subject comprehends spoken and written English
Exclusion Criteria:
1. Subject has a medical disorder that in the judgment of the investigator will interfere with completion of any aspect of the protocol.
2. Subject has a neurologic disorder that in the judgment of the investigator will affect completion of the protocol.
Intervention(s):
behavioral: ONBOARD
Recruiting
I'm InterestedContact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Molly Tanenbaum, PhD
650-725-3955